LND topic: pfizer page 1

pfizer

Pfizer's Move: Should You Reconsider BNTX Stock?

November 25, 2025

Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s

health

Awarding Trump for COVID-19 Vaccine Push: A Debate

September 9, 2025

The CEO of Pfizer, Albert Boura, has suggested that former President Donald Trump should be considered for the Nobel Peace Prize. This is due to Trump's role in speeding up the creation and distribution of the COVID-19 vaccine. Boura highlighted the success of Operation Warp Speed, a program started

health

Pregnant Women's Health at Risk Due to Penicillin Shortage

July 30, 2025

A critical shortage of a key antibiotic is raising concerns about the health of pregnant women. Pfizer, a major pharmaceutical company, has announced that it will have limited supplies of Bicillin LA. This drug is crucial for treating syphilis in pregnant women. The shortage comes after Pfizer recal

health

Pfizer's CEO Speaks Out on Vaccine Controversy

June 2, 2025

The US Department of Health and Human Services recently made a bold move. They ended a contract with Moderna. The contract was for developing an mRNA vaccine for bird flu. The reason given was that mRNA technology is not well-tested. This decision sparked a response from Pfizer's CEO, Dr. Albert Bou

politics

Text Messages Under Scrutiny: EU Court Orders Release of Pfizer Communications

May 19, 2025

A significant ruling came down from the European Court of Justice. The court ordered the release of text messages exchanged between European Commission President Ursula von der Leyen and Pfizer CEO Albert Bourla. This decision came after a lengthy battle for transparency. The New York Times

business

Pfizer's Q4 2024: Beating Expectations, Facing Challenges

February 4, 2025

Pfizer recently shared its fourth-quarter 2024 earnings. Their reported sales for COVID-19 products skyrocketed beyond what experts had guessed. This achievement was made possible by the company’s ongoing efforts to reduce costs. Shares of Pfizer went up by 2% in early trading. This jump ca

health

Sounds in Health: Spotting Respiratory Issues with AI

January 7, 2025

Imagine you're a doctor. You need to know if a patient's cough or sneeze is just a passing thing or a sign of something bigger. That's where machine learning comes in. Researchers created an automatic system to spot sneezes and coughs, sounds that can hint at respiratory problems. The goal? Early di

education

Chat with Stephen E. Fienberg: Unveiling the World of Statistics

November 22, 2024

Stephen E. Fienberg, a distinguished statistician, was recently interviewed as part of a special series honoring the late Professor Harry O. Posten. The chat, supported by Pfizer Global Research-Connecticut, the American Statistical Association, and the University of Connecticut-Storrs, dived into F

health

Boosting Vaccine Efficacy with Bayesian Methods

November 22, 2024

Did you know that the way we estimate how well vaccines work can be improved? Currently, scientists use a method that relies on the total number of cases to figure out vaccine efficacy. But a new approach, called the full Bayesian method, is making waves. This method is like a smarter way to estimat

business

Pfizer's Surprising Q3 Win: Paxlovid and Vaccines Boost Sales

October 30, 2024

Pfizer recently shared impressive Q3 results that overshot expectations, thanks to its Covid vaccine and antiviral pill, Paxlovid. The drug giant raised its earnings and revenue projections for the year. Despite the positive news, shares dropped by over 2%. Pfizer's CEO, Albert Bourla, is under pres